↓ Skip to main content

Methylphenidate off-label use and safety

Overview of attention for article published in SpringerPlus, June 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet
twitter
10 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
109 Mendeley
Title
Methylphenidate off-label use and safety
Published in
SpringerPlus, June 2014
DOI 10.1186/2193-1801-3-286
Pubmed ID
Authors

Thierry Trenque, Emmanuelle Herlem, Malak Abou Taam, Moustapha Drame

Abstract

Methylphenidate is a piperidine derivative structurally and pharmacologically similar to amphetamine. Methylphenidate is indicated for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 years of age and over when remedial measures alone prove insufficient. In adults, its indication, except in narcolepsy, is not defined. Methylphenidate received regulatory approval almost sixty years ago with a first registration in Switzerland in October 1954.

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Finland 1 <1%
Brazil 1 <1%
Unknown 107 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 15%
Student > Bachelor 16 15%
Researcher 14 13%
Other 9 8%
Student > Ph. D. Student 8 7%
Other 19 17%
Unknown 27 25%
Readers by discipline Count As %
Medicine and Dentistry 24 22%
Psychology 22 20%
Pharmacology, Toxicology and Pharmaceutical Science 9 8%
Agricultural and Biological Sciences 5 5%
Neuroscience 5 5%
Other 14 13%
Unknown 30 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2023.
All research outputs
#1,784,926
of 23,351,247 outputs
Outputs from SpringerPlus
#99
of 1,856 outputs
Outputs of similar age
#18,683
of 230,154 outputs
Outputs of similar age from SpringerPlus
#8
of 75 outputs
Altmetric has tracked 23,351,247 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,856 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,154 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.